Search Results - "Horwitz, E.M."

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement by Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F.C, Krause, D.S., Deans, R.J., Keating, A., Prockop, D.J., Horwitz, E.M.

“…The considerable therapeutic potential of human multipotent mesenchymal stromal cells (MSC) has generated markedly increasing interest in a wide variety of…”
Get full text

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement by Horwitz, E.M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S., Keating, A.

“…The plastic-adherent cells isolated from BM and other sources have come to be widely known as mesenchymal stem cells (MSC). However, the recognized biologic…”
Get full text

Applying ASTRO APEx Guidelines and RO-ILS to Medical Malpractice in Radiation Oncology by Zaorsky, N.G, Ricco, A, Churilla, T.M, Horwitz, E.M, Den, R.B

Get full text

Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer by Zaorsky, N.G, Handorf, E, Horwitz, E.M, Hallman, M.A, Smaldone, M.C

Get full text

Evaluation of Biologically Equivalent Dose Escalation and Patient Outcomes Among International Randomized Controlled Trials of Conventionally Fractionated and Hypofractionated Radiation Therapy: A Meta-Analysis of 6800 Patients by Zaorsky, N.G, Keith, S.W, Dicker, A.P, Horwitz, E.M, Den, R.B

Get full text

Quality Adjusted Survival Comparing Standard Versus Hypofractionated Radiation Therapy in the Treatment of Prostate Cancer by Konski, A.A, Buyyounouski, M.K, Stoyanova, R, Movsas, B, Uzzo, R, Horwitz, E.M, Kwon, D, Bruner, D, Pollack, A

Get full text

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy by Dong, Y, Ruth, K, Churilla, T, Viterbo, R, Sobczak, M.L, Smaldone, M.C, Chen, D, Uzzo, R, Hallman, M.A, Horwitz, E.M

Get full text

Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients With Prostate Cancer Treated With Definitive Radiation by Dong, Y, Li, T, Churilla, T, Viterbo, R, Sobczak, M.L, Smaldone, M.C, Chen, D, Uzzo, R, Hallman, M.A, Horwitz, E.M

Get full text

Type 2 Diabetes Mellitus, Oral Antihyperglycemics, Insulin Use, and Outcomes Among Men Receiving Radiation Therapy for Prostate Cancer by Zaorsky, N.G, Ruth, K, Shaikh, T, Smaldone, M.C, Hallman, M.A, Slifker, M, Hayes, S.B, Sobczak, M.L, Horwitz, E.M

Get full text

Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis by Kishan, A.U, Shaikh, T, Wang, J, Reiter, R, Said, J, Raghavan, G, Nickols, N, Aronson, W, Sadeghi, A, Kamrava, M, Demanes, D.J, Steinberg, M.L, Horwitz, E.M, Kupelian, P.A, King, C.R

Get full text

Efficacy of Pulsed Low-Dose-Rate Reirradiation: Results From a Phase 1 Clinical Trial by Meyer, J.E, Galloway, T.J, Ruth, K, Ross, E.A, Buyyounouski, M.K, Klayton, T.L, Hallman, M.A, Weiss, S.E, Hayes, S.B, Leahy, J, Duncan, G, Price, R.A, Horwitz, E.M, Ma, C.M.C

Get full text

Dosimetric and Clinical Predictors of Long-Term Toxicity in Patients Undergoing Hypofractionated Prostate Radiation Therapy: Results From a Randomized Phase 3 Trial by Shaikh, T, Ruth, K, Devarajan, K, Zaorsky, N.G, Hallman, M.A, Sobczak, M.L, Chen, D, Uzzo, R, Smaldone, M.C, Kutikov, A, Greenberg, R.E, Viterbo, R, Pollack, A, Horwitz, E.M

Get full text

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM by Müller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M.P., Horwitz, E.M., Conte, P., Handgretinger, R., Dominici, M.

“…Multipotent mesenchymal stromal cells (MSC) have become important tools in regenerative and transplantation medicine. Rapidly increasing numbers of patients…”
Get full text

Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer by Johnson, S.B, Soulos, P.R, Shafman, T.D, Mantz, C.A, Dosoretz, A, Ross, R, Finkelstein, S.E, Collins, S.P, Suy, S, Brower, J.V, Ritter, M.A, King, C.R, Kupelian, P.A, Horwitz, E.M, Pollack, A, Abramowitz, M.C, Hallman, M.A, Faria, S, Gross, C.P, Yu, J.B

Get full text

CT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques by Chen, X, Xue, J, Chen, L, Buyyounouski, M.K, Horwitz, E.M, Wang, L, Ma, C

Get full text

Phase I Study of Pulsed Low Dose-Rate Reirradiation: A Dose-Escalation Study to Establish Maximum Tolerated Dose by Meyer, J.E, Galloway, T.J, Ross, E.A, Buyyounouski, M.K, Hayes, S.B, Klayton, T.L, Hallman, M.A, Weiss, S.E, Leahy, J, Duncan, G, Price, R.A, Horwitz, E.M, Ma, C.M.C

Get full text

Men’s Health Supplement Use and Outcomes Among Men Receiving Definitive IMRT for Localized Prostate Cancer by Zaorsky, N.G, Churilla, T.M, Ruth, K, Slifker, M, Hallman, M.A, Hayes, S.B, Sobczak, M.L, Chen, D, Viterbo, R, Smaldone, M.C, Horwitz, E.M

Get full text

Long-term Patient Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated IMRT Radiation Therapy for Localized Prostate Cancer by Shaikh, T, Li, T, Johnson, M.E, Wang, L, Hallman, M.A, Greenberg, R.E, Price, R.A, Uzzo, R, Ma, C.M.C, Chen, D, Pollack, A, Horwitz, E.M

Get full text

A Multi-institutional Phase 2 Trial Assessing Quality of Life (QOL) After Electromagnetic Transponder Guided Prostate Stereotactic Body Radiation Therapy (SBRT) by Jackson, W.C, Litzenberg, D.W, Schipper, M, Wei, J, Rosenthal, S.A, Chang, G.C, Horwitz, E.M, Li, J, Michalski, J.M, Gay, H.A, Feng, F.Y, Sandler, H.M, Wallace, R.E, Hamstra, D.A

Get full text

Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck by GARDEN, A. S, HARRIS, J, DEMAS, W, GORE, E, VOKES, E. E, FORASTIERE, A. A, RIDGE, J. A, JONES, C, HORWITZ, E. M, GLISSON, B. S, NABELL, L, COOPER, J. S

“…To define further the role of concurrent chemoradiotherapy for patients with advanced squamous carcinoma of the head and neck. The Radiation Therapy Oncology…”
Get full text